Literature DB >> 19455132

A treatment trial of acupuncture in IBS patients.

Anthony J Lembo1, Lisa Conboy, John M Kelley, Rosa S Schnyer, Claire A McManus, Mary T Quilty, Catherine E Kerr, Doug Drossman, Eric E Jacobson, Roger B Davis.   

Abstract

OBJECTIVES: This study aimed to compare the effects of true and sham acupuncture in relieving symptoms of irritable bowel syndrome (IBS).
METHODS: A total of 230 adult IBS patients (75 % females, average age: 38.4 years) were randomly assigned to 3 weeks of true or sham acupuncture (6 treatments) after a 3-week "run-in" with sham acupuncture in an "augmented" or "limited" patient-practitioner interaction. A third arm of the study included a waitlist control group. The primary outcome was the IBS Global Improvement Scale (IBS-GIS) (range: 1 - 7); secondary outcomes included the IBS Symptom Severity Scale (IBS-SSS), the IBS Adequate Relief (IBS-AR), and the IBS Quality of Life (IBS-QOL).
RESULTS: Although there was no statistically significant difference between acupuncture and sham acupuncture on the IBS-GIS (41 vs. 32 % , P = 0.25), both groups improved significantly compared with the waitlist control group (37 vs. 4 % , P = 0.001). Similarly, small differences that were not statistically significant favored acupuncture over the other three outcomes: IBS-AR(59 vs. 57 % , P = 0.83), IBS-SSS (31 vs. 21 % , P = 0.18), and IBS-QOL (17 vs. 13 % , P = 0.56). Eliminating responders during the run-in period did not substantively change the results. Side effects were generally mild and only slightly greater in the acupuncture group.
CONCLUSIONS: This study did not find evidence to support the superiority of acupuncture compared with sham acupuncture in the treatment of IBS.

Entities:  

Mesh:

Year:  2009        PMID: 19455132      PMCID: PMC2694961          DOI: 10.1038/ajg.2009.156

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  44 in total

Review 1.  Acupuncture: theory, efficacy, and practice.

Authors:  Ted J Kaptchuk
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

Review 2.  Bridging the gap in complementary and alternative medicine research: manualization as a means of promoting standardization and flexibility of treatment in clinical trials of acupuncture.

Authors:  Rosa N Schnyer; John J B Allen
Journal:  J Altern Complement Med       Date:  2002-10       Impact factor: 2.579

3.  Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.

Authors:  T Lembo; R A Wright; B Bagby; C Decker; S Gordon; P Jhingran; E Carter
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

4.  Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

Authors:  D A Drossman; D L Patrick; W E Whitehead; B B Toner; N E Diamant; Y Hu; H Jia; S I Bangdiwala
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 5.  Systematic review: the economic impact of irritable bowel syndrome.

Authors:  J M Inadomi; M B Fennerty; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2003-10-01       Impact factor: 8.171

6.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation.

Authors:  Sandra Lee; John R Walker; Laura Jakul; Kathryn Sexton
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

8.  Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy.

Authors:  Susan Gordon; Vanessa Ameen; Barbara Bagby; Britt Shahan; Priti Jhingran; Eric Carter
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.

Authors:  Ted J Kaptchuk; John M Kelley; Lisa A Conboy; Roger B Davis; Catherine E Kerr; Eric E Jacobson; Irving Kirsch; Rosa N Schyner; Bong Hyun Nam; Long T Nguyen; Min Park; Andrea L Rivers; Claire McManus; Efi Kokkotou; Douglas A Drossman; Peter Goldman; Anthony J Lembo
Journal:  BMJ       Date:  2008-04-03

Review 10.  The epidemiology of irritable bowel syndrome in North America: a systematic review.

Authors:  Yuri A Saito; Philip Schoenfeld; G Richard Locke
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  41 in total

Review 1.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 2.  Acupuncture for treatment of irritable bowel syndrome.

Authors:  Eric Manheimer; Ke Cheng; L Susan Wieland; Li Shih Min; Xueyong Shen; Brian M Berman; Lixing Lao
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.

Authors:  Sarah Ballou; Alissa Beath; Ted J Kaptchuk; William Hirsch; Thomas Sommers; Judy Nee; Johanna Iturrino; Vikram Rangan; Prashant Singh; Mike Jones; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-12       Impact factor: 11.382

4.  Functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Therapy       Date:  2011-05-01

Review 5.  Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 3.869

6.  The past, the present, and the future in the gastrointestinal health of women: An interview with Dr Jacqueline L Wolf.

Authors:  Jacqueline L Wolf
Journal:  Womens Health (Lond)       Date:  2016-07

Review 7.  Gastrointestinal motility disorders and acupuncture.

Authors:  Jieyun Yin; Jiande D Z Chen
Journal:  Auton Neurosci       Date:  2010-04-03       Impact factor: 3.145

8.  ZD 7288, an HCN channel blocker, attenuates chronic visceral pain in irritable bowel syndrome-like rats.

Authors:  Yu Chen; Chun Lin; Ying Tang; Ai-Qin Chen; Cui-Ying Liu; Da-Li Lu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

9.  Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis.

Authors:  Guan-Qun Chao; Shuo Zhang
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 10.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.